Scientists have discovered why some heart tissue turns into bone, and they may have learned how to stop it.
Jeanne Paz, PhD, an assistant investigator at the Gladstone Institutes, has been awarded the prestigious Michael Prize, honoring her significant contributions to the field of epilepsy.
Groundbreaking discovery challenges the conventional theory that infected host cells control latency and could open the door to new pathways.
Raising levels of the life-extending protein klotho can protect against learning and memory deficits in a mouse model of Alzheimer’s disease, despite the accumulation of Alzheimer-related toxins in the brain.
By helping cells switch their type, we may have discovered a new way to repair damaged hearts, and potentially revolutionize the future of medicine.
Katerina Akassoglou is working to identify a biomarker that could track the progression of multiple sclerosis using blood tests
Protein interactions between viruses and cells can illuminate common weak points in human biology and reveal potential new targets for antiviral treatments.
Pre-exposure prophylaxis, or PrEP, may be the key to helping San Francisco become the first city to stop HIV.
At the Gladstone Institute of Neurological Disease, two distinguished scientists are exploring Parkinson’s disease from all angles—gaining critical insights about the condition.
Recent discoveries made at the Gladstone Institutes have provided new hope in the search for a cure for HIV/AIDS.
Advances made in the fields of virology and immunology often spread from one disease to another.
The postdoctoral fellows will use the grants to pursue research into epigenetics and heart disease, and the role of ketone bodies in aging.
New generation of microbicides should contain compounds that break down amyloid fibrils in semen in order to increase drugs’ effectiveness.
Honor recognizes researchers and physicians who have made significant contributions to the field of medical science.
Low levels of the naturally occurring protein progranulin exacerbate cellular and cognitive dysfunction, while raising levels can prevent abnormalities in an Alzheimer model.
Todd McDevitt will use his background in biomedical engineering to improve and accelerate the development of human tissues from stem cells.
Grants are to be used for innovative and transformative research into the detailed cell biology of the brain.
Underrepresented high school and community college students spent the summer at the Gladstone Institutes conducting hands-on research and learning about what it means to be a scientist.
With his unique combination of biology and chemistry, Gladstone’s Sheng Ding is quickly becoming a tour-de-force in the field of regenerative medicine.
New gift from long-time supporter William Younger is helping two top scientists repair damaged hearts and prevent damage in developing ones.
A joint Gladstone-UCSF study reveals a gene linked to longevity also improves learning and memory. This discovery opens a new path for treating Alzheimer's and other aging-related diseases.
Warner Greene, the Director of the Gladstone Institute of Virology and Immunology, was recently elected into The American Academy of Arts and Sciences for his outstanding contributions to basic science research.
Gladstone’s innovative technique in stem cells could boost scientists’ ability to study—and ultimately cure—genetic disease.
A cure for type 1 diabetes has long eluded even the top experts. Not because they do not know what must be done—but because the tools did not exist to do it.
New study establishes platform for investigating chromosome regulation during early human development.